Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Stemler, Jannik  [Clear All Filters]
2023
Salmanton-García J, Hoenigl M, Salzer HJF, Lackner M, Prattes J, Dichtl K, Winkler-Zamani M, Krause R, Stemler J, Lass-Flörl C, et al. The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections. Mycoses. 2023.
Orth HMartin, Flasshove C, Berger M, Hattenhauer STessa, Biederbick KD, Mispelbaum R, Klein U, Stemler J, Fisahn M, Doleschall AD, et al. Early combination therapy of COVID-19 in high-risk patients. Infection. 2023.
2022
Giesen N, Busch E, Schalk E, Beutel G, Rüthrich MM, Hentrich M, Hertenstein B, Hirsch HH, Karthaus M, Khodamoradi Y, et al. AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants. Eur J Cancer. 2022;181:102-118.
Stemler J, de Jonge N, Skoetz N, Sinkó J, Brüggemann RJ, Busca A, Ben-Ami R, Racil Z, Piechotta V, Lewis R, et al. Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association. Lancet Haematol. 2022;9(5):e361-e373.
2019
Stemler J, Salmanton-García J, Seidel D, Alexander B, Bertz H, Hoenigl M, Herbrecht R, Meintker L, Meißner A, Mellinghoff SC, et al. Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature. Mycoses. 2019.